Anzeige
Mehr »
Sonntag, 05.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EKSE | ISIN: JE00BPSKDR41 | Ticker-Symbol:
NASDAQ
16.07.25 | 21:57
0,038 US-Dollar
+1,08 % +0,000
Branche
Öl/Gas
Aktienmarkt
Sonstige
1-Jahres-Chart
CROWN LNG HOLDINGS LIMITED Chart 1 Jahr
5-Tage-Chart
CROWN LNG HOLDINGS LIMITED 5-Tage-Chart

Aktueller Chart CROWN LNG Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
CROWN LNG HOLDINGS LIMITED-Investoren interessieren sich auch für diese Wertpapiere
SNDL Inc.: SNDL Announces 2025 Annual and Special Meeting ResultsEDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders...
► Artikel lesen
SNDL Inc.: SNDL Reports Second Quarter 2025 Financial and Operational ResultsThe Company Delivers Positive Operating Income EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") reported...
► Artikel lesen
1CM Inc.: 1CM Receives Court Approval for Arrangement with SNDL IncToronto, Ontario--(Newsfile Corp. - June 18, 2025) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM" or the "Company") is pleased to announce that the Ontario Superior Court of Justice (Commercial...
► Artikel lesen
Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market AccessMr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya (cyclobenzaprine...
► Artikel lesen
Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Plans to Initiate Prader-Willi Syndrome Phase 2 Trial of TNX-2900 (Intranasal Potentiated Oxytocin) in 2026Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900...
► Artikel lesen
Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive DisorderTonix anticipates filing the IND application in the fourth quarter of 2025 TNX-102 SL is a potential first-in-class treatment for targeting the disturbed sleep associated with depression TNX-102 SL...
► Artikel lesen
Lithium Chile Inc.: Lithium Chile Announces Upsized Life Offering of Up to $7,000,000NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS. CALGARY, Alberta, Sept. 24, 2025...
► Artikel lesen
Lithium Chile Inc.: Lithium Chile Announces Upsized Life Offering of up to $6,500,000NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS. CALGARY, Alberta, Sept. 18, 2025...
► Artikel lesen